Please use this identifier to cite or link to this item:
Title: The matrix proteins aggrecan and fibulin-1 play a key role in determining aortic stiffness
Authors: Yasmin
Maskari, RA
McEniery, CM
Cleary, SE
Li, Y
Siew, K
Figg, NL
Khir, AW
Cockcroft, JR
Wilkinson, IB
O'Shaughnessy, KM
Issue Date: 4-Jun-2018
Publisher: Nature Publishing Group
Citation: Yasmin, Al Maskari, R., McEniery, C.M., Cleary, S.E., Li, Y., Siew, K., Figg, N.L., Khir, A.W., Cockcroft, J.R., Wilkinson, I.B. and O’Shaughnessy, K.M. (2018) 'The matrix proteins aggrecan and fibulin-1 play a key role in determining aortic stiffness', Scientific Reports, 2018, 8(1): 8550 pp. 1-16. doi: 10.1038/s41598-018-25851-5.
Abstract: © The Author(s) 2018. Stiffening of the aorta is an important independent risk factor for myocardial infarction and stroke. Yet its genetics is complex and little is known about its molecular drivers. We have identified for the first time, tagSNPs in the genes for extracellular matrix proteins, aggrecan and fibulin-1, that modulate stiffness in young healthy adults. We confirmed SNP associations with ex vivo stiffness measurements and expression studies in human donor aortic tissues. Both aggrecan and fibulin-1 were found in the aortic wall, but with marked differences in the distribution and glycosylation of aggrecan reflecting loss of chondroitin-sulphate binding domains. These differences were age-dependent but the striking finding was the acceleration of this process in stiff versus elastic young aortas. These findings suggest that aggrecan and fibulin-1 have critical roles in determining the biomechanics of the aorta and their modification with age could underpin age-related aortic stiffening.
ISSN: 2045-2322
Appears in Collections:Dept of Mechanical and Aerospace Engineering Research Papers

Files in This Item:
File Description SizeFormat 
Fulltext.pdf3.32 MBAdobe PDFView/Open

This item is licensed under a Creative Commons License Creative Commons